Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct french information data sets

Haematologica

Volumn 100, Issue 9, 2015, Pages e361-e364

  de Leval, Laurence ^a   Parrens, Marie ^b   Le Bras, Fabien ^c   Jais, Jean Philippe ^d   Fataccioli, Virginie ^c   Martin, Antoine ^e   Lamant, Laurence ^f   Delarue, Richard ^d   Berger, Françoise ^g   Arbion, Flavie ^h   Bossard, Céline ⁱ   Copin, Marie Christine ^j   Canioni, Danielle ^d   Charlotte, Frédéric ^k   Damaj, Gandhi ^l   Dartigues, Peggy ^m   Fabiani, Bettina ⁿ   Ledoux Pilon, Albane ^o   Montagne, Karine ^p   Molina, Thierry ^d   Patey, Martine ^q   Tas, Patrick ^r   Peoch, Michel ^s   Petit, Barbara ^t   Petrella, Tony ^u   Picquenot, Jean Michel ^v   Rousset, Thérèse ^w   Rousselet, Marie Christine ^x   Soubeyran, Isabelle ^y   Thiebault, Sylvie ^z   Tournilhac, Olivier ^aa   Xerri, Luc ^ab   Gisselbrecht, Christian ^ac   Haioun, Corinne ^c   Delsol, Georges ^f   Gaulard, Philippe ^c,ad,ae   more..

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Hôpital Pessac   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e AVICENNE HOSPITAL   (France)

^f CHU PURPAN   (France)

^g CENTRE HOSPITALIER LYON SUD   (France)

^h CHU BRETONNEAU   (France)

ⁱ HÔTEL DIEU   (France)

^j LILLE UNIVERSITY HOSPITAL   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l CAEN UNIVERSITY HOSPITAL   (France)

^m INSTITUT GUSTAVE ROUSSY   (France)

ⁿ HÔPITAL SAINT ANTOINE   (France)

^o HÔTEL DIEU   (France)

^p CHU NANCY BRABOIS   (France)

^q SERVICE DE DERMATOLOGIE   (France)

^r PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^s UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^t DUPUYTREN UNIVERSITY HOSPITAL   (France)

^u DIJON UNIVERSITY HOSPITAL   (France)

^v CENTRE HENRI BECQUEREL   (France)

^w GUI DE CHAULIAC HOSPITAL   (France)

^x ANGERS UNIVERSITY HOSPITAL   (France)

^y INSTITUT BERGONIÉ   (France)

^z CENTRE HOSPITALIER DE MULHOUSE   (France)

^aa UNIVERSITÉ CLERMONT AUVERGNE   (France)

^ab INSTITUT PAOLI CALMETTES   (France)

^ac SAINT LOUIS HOSPITAL   (France)

^ad INSERM U955   (France)

^ae UNIVERSITÉ PARIS EST CRÉTEIL   (France)

more..

Author keywords

Angioimmunoblastic T cell lymphoma; Epidemiology; France; Peripheral T cell lymphoma; Prevalence

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CXCL13 CHEMOKINE; PROTEIN BCL 6;

CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; COOMBS TEST; DNA METHYLATION; GENE MUTATION; HUMAN; HYPERGAMMAGLOBULINEMIA; LARGE CELL LYMPHOMA; LETTER; OVERALL SURVIVAL; PREVALENCE; PROTEIN EXPRESSION; T CELL LYMPHOMA; TREATMENT OUTCOME; CLINICAL TRIAL; FACTUAL DATABASE; FEMALE; FRANCE; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPHOMA, T-CELL; MALE; MULTICENTER STUDY; PATHOLOGY;

DATABASES, FACTUAL; FEMALE; FRANCE; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPHOMA, T-CELL; MALE;

EID: 84940940450     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.126300     Document Type: Letter

References (16)

1. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 1998;9(7):717-20.
2. Swerdlow S, Campo E, Harris N, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2008.
3. Melnyk A, Rodriguez A, Pugh W, et al. Evaluation of the Revised European-American Lymphoma classificaiton confirms the clinical relevance of immunophenotype in 560 cases of aggressive non- Hodgkin’s lymphoma. Blood. 1997;89: 4514-4520.
4. Lopez-Guillermo A, Cid J, Salar A, et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol. 1998;9(8):849-855.
5. Vose J, Armitage J, Weisenburger D. International TCLP. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124-4130.
6. Ellin F, Landstrom J, Jerkeman M, et al. Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry. Blood. 2014;124(10):1570-1577.
7. Attygalle AD, Cabecadas J, Gaulard P, et al. Peripheral T-cell and NKcell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology. 2014;64(2):171-199.
8. Mourad N, Mounier N, Briere J, et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d’Etude des Lymphomes de l'Adulte (GELA) trials. Blood. 2008;111(9):4463-4470.
9. Lachenal F, Berger F, Ghesquieres H, et al. Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients. Medicine (Baltimore). 2007;86(5):282-292.
10. Federico M, Rudiger T, Bellei M, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013; 31(2):240-246.
11. Tokunaga T, Shimada K, Yamamoto K, et al. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan. Blood. 2012;119(12):2837-2843.
12. Moskowitz AJ, Lunning MA, Horwitz SM. How I treat the peripheral T-cell lymphomas. Blood. 2014;123(17):2636-2644.
13. Lemonnier F, Couronne L, Parrens M, et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood. 2012;120(7):1466-1469.
14. Cairns RA, Iqbal J, Lemonnier F, et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood. 2012;119(8):1901-1903.
15. Sakata-Yanagimoto M, Enami T, Yoshida K, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(2):171-175.
16. Cheminant M, Bruneau J, Kosmider O, et al. Efficacy of 5-Azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma. Br J Haematol. 2015;168(6):913-916.